Clinical Trials in Boston

Showing 4481-4500 of 17,836 trials

Nerve Excitability in Cisplatin-Induced Peripheral Neuropathy

NCT07095998

This study aims to evaluate nerve excitability in participants with cisplatin-induced peripheral neuropathy (cis-PN) using threshold tracking nerve conduction studies (TTNCS). By assessing changes in nerve excitability parameters, the study seeks to enhance understanding of the pathophysiology of cis-PN and identify early markers of neurotoxicity in participants undergoing cisplatin-based chemotherapy.

Peripheral Neuropathy Due to ChemotherapyPeripheral NeuropathyNeurotoxicity Syndromes+1 more

Ka-Wai Ho60 participantsStarted Aug 2025

Boston, Massachusetts, United States • Boston, Massachusetts, United States

COMPLETEDPhase 2< 1 mile

Study to Evaluate EP547 in Subjects With Cholestatic Pruritus Due to Primary Biliary Cholangitis or Primary Sclerosing Cholangitis

NCT05525520

This phase 2 trial will evaluate the effects of EP547 in subjects with cholestatic pruritus due to Primary Biliary Cholangitis (PBC) or Primary Sclerosing Cholangitis (PSC)

Pruritus

Escient Pharmaceuticals, Inc62 participantsStarted Oct 2022

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Coronado, California, United States +49 more locations

Nerve Excitability in Cisplatin-Induced Peripheral Neuropathy

Study to Evaluate EP547 in Subjects With Cholestatic Pruritus Due to Primary Biliary Cholangitis or Primary Sclerosing Cholangitis

Find Trials by Condition in Boston

VentaProst Versus Conventionally-Administered Aerosolized Epoprostenol in Patients Undergoing Cardiac Surgery With CPB

Using WHOOP Fitness Band to Measure Heart Health Variability Before and After Surgery

A Study of AGEN2034 in Advanced Tumors and Cervical Cancer

The Actuate-CBC Study

Risk-adapted Therapy in HPV+ Oropharyngeal Cancer Using Circulating Tumor (ct)HPV DNA Profile - The ReACT Study

Texting to Reduce Human Immunodeficiency Virus (HIV) Risk

Axi-cel in CNS Lymphoma

Enlighten Study: The EV-ICD Post Approval Registry

Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Intervention With Statin and Colchicine

Optisure Lead Post Approval Study

Dating Violence Prevention Program Focusing on Middle School Boys

Portico Next Generation Approval Study

Phase 3 Study to Evaluate the Safety and Efficacy of Hydrocortisone Acetate Suppositories

Topical Ruxolitinib Evaluation in Chronic Hand Eczema

Study of BEST1 Vitelliform Macular Dystrophy

RADIQAL Study (Radiation Dose and Image Quality Trial)

A Study to Evaluate RL-007 in the Treatment of Cognitive Impairment Associated With Schizophrenia (CIAS)

A Study of Obexelimab in Patients With Systemic Lupus Erythematosus